Parks, V.
836  Ergebnisse:
Personensuche X
?
1

Concomitant blockade of 5-HT1A receptor and 5-HT transporte..:

Parks, V. ; Philipp, A.W. ; Raje, S....
European Neuropsychopharmacology.  22 (2012)  2 - p. 92-99 , 2012
 
?
3

P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in ..:

Parks, V. ; Patat, A. ; Raje, S...
European Neuropsychopharmacology.  20 (2010)  - p. S320 , 2010
 
?
4

Numbering Photographs:

PARKS, V.J.
Experimental Techniques.  7 (2008)  11 - p. 16-16 , 2008
 
?
5

P.1.c.039 Concomitant blockade of 5-HT1a receptor and 5-HT ..:

Parks, V. ; Chalon, S. ; Raje, S....
European Neuropsychopharmacology.  18 (2008)  - p. S241-S242 , 2008
 
?
6

Reducing Errors from the Electronic Transcription of Data C..:

Wahi, M. M. ; Parks, D. V. ; Skeate, R. C..
Journal of the American Medical Informatics Association.  15 (2008)  3 - p. 386-389 , 2008
 
?
7

A Positron Emission Tomography Study to Assess Binding of L..:

Raje, S ; Patat, A A ; Parks, V...
Clinical Pharmacology & Therapeutics.  83 (2007)  1 - p. 86-96 , 2007
 
?
8

Ultrasound‐guided follicular aspiration in squirrel monkeys:

Schuler, A.M. ; Westberry, J.M. ; Parks, V.L...
Journal of Medical Primatology.  36 (2007)  2 - p. 113-117 , 2007
 
?
9

PI-71Absence of drug interaction between rotigaptide (ZP123..:

UDATA, C ; PARKS, V ; PATAT, A..
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P25-P25 , 2006
 
?
10

PIII-39Safety, tolerability and pharmacokinetics (PK) of mu..:

PARKS, V ; RAJE, S ; PATAT, A...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P68-P68 , 2006
 
?
11

PI-34Use of positron emission tomography (PET) to assist in..:

PATAT, A ; RAJE, S ; LANGSTROM, B...
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P16-P16 , 2006
 
?
12

PII-33Relative bioavailability of three modified release fo..:

RAJE, S ; PARKS, V ; PLOTKA, A..
Clinical Pharmacology & Therapeutics.  79 (2006)  2 - p. P45-P45 , 2006
 
?
13

Safety, pharmacokinetics (Pk) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics.  77 (2005)  2 - p. P44-P44 , 2005
 
?
14

Safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics.  77 (2005)  2 - p. P28-P28 , 2005
 
?
15

Age-gender study of SRA-333, a novel 5-HT antagonist:

PATAT, A ; PARKS, V ; RAJE, S..
Clinical Pharmacology & Therapeutics.  77 (2005)  2 - p. P29-P29 , 2005
 
1-15